•  
  •  
 

Document Type

Article

Media Type

Text

Abstract

From the birth of bioethics in the United States to the hindrance of advancement caused by laws that claim to remove barriers to innovation, CRISPR and its germline editing abilities simply cannot live up to their full potential in the United States unless current limitations are lifted and a more reasonable approach is taken. While scientific acronyms and analogies to scissors and word processing functions abound in CRISPR-related articles, many focus on the patent for the technology itself. Few seek to resolve the discord that abounds in federal regulations of this emerging biotechnology. This Comment seeks to do just that and advocates for the adoption of the 2017 American Society of Human Genetics position statement as a rational and research-based approach.

First Page

585

Last Page

620

Publication Date

6-1-2018

Department

College of Law

ISSN

0734-1490

Language

eng

Publisher

Northern Illinois University Law Review

Included in

Law Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.